SUPRIYA LIFESCIENCE
|
SUPRIYA LIFESCIENCE Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
| Equity - Authorised | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr |
| Equity - Issued | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
| Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹981 Cr | ₹799 Cr | ₹683 Cr | ₹600 Cr | ₹254 Cr |
| Securities Premium | ₹199 Cr | ₹199 Cr | ₹199 Cr | ₹199 Cr | - |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹782 Cr | ₹600 Cr | ₹486 Cr | ₹401 Cr | ₹254 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹0.16 Cr | ₹0.28 Cr | ₹-1.34 Cr | ₹-0.08 Cr | ₹0.23 Cr |
| Reserve excluding Revaluation Reserve | ₹981 Cr | ₹799 Cr | ₹683 Cr | ₹600 Cr | ₹254 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹997 Cr | ₹815 Cr | ₹699 Cr | ₹616 Cr | ₹269 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹27 Cr | ₹23 Cr | ₹14 Cr | ₹11 Cr | ₹8.01 Cr |
| Deferred Tax Assets | ₹1.21 Cr | ₹1.70 Cr | ₹3.17 Cr | ₹2.40 Cr | ₹0.67 Cr |
| Deferred Tax Liability | ₹28 Cr | ₹25 Cr | ₹17 Cr | ₹14 Cr | ₹8.68 Cr |
| Other Long Term Liabilities | ₹5.06 Cr | ₹5.02 Cr | ₹5.49 Cr | ₹5.30 Cr | ₹22 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹1.32 Cr | ₹0.80 Cr | ₹5.88 Cr | ₹2.93 Cr | ₹1.30 Cr |
| Total Non-Current Liabilities | ₹33 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹31 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹75 Cr | ₹60 Cr | ₹64 Cr | ₹49 Cr | ₹51 Cr |
| Sundry Creditors | ₹75 Cr | ₹60 Cr | ₹64 Cr | ₹49 Cr | ₹51 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹11 Cr | ₹20 Cr | ₹9.50 Cr | ₹23 Cr | ₹11 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹4.36 Cr | ₹15 Cr | ₹5.51 Cr | ₹18 Cr | ₹0.94 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹7.10 Cr | ₹4.77 Cr | ₹4.00 Cr | ₹4.78 Cr | ₹11 Cr |
| Short Term Borrowings | - | - | ₹17 Cr | ₹21 Cr | ₹67 Cr |
| Secured ST Loans repayable on Demands | - | - | ₹17 Cr | ₹21 Cr | ₹66 Cr |
| Working Capital Loans- Sec | - | - | ₹17 Cr | ₹21 Cr | ₹66 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | ₹-17 Cr | ₹-21 Cr | ₹-65 Cr |
| Short Term Provisions | ₹1.19 Cr | ₹0.37 Cr | ₹5.42 Cr | ₹6.82 Cr | ₹16 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | ₹4.59 Cr | ₹6.41 Cr | ₹15 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹1.19 Cr | ₹0.37 Cr | ₹0.84 Cr | ₹0.41 Cr | ₹0.91 Cr |
| Total Current Liabilities | ₹87 Cr | ₹80 Cr | ₹96 Cr | ₹100 Cr | ₹146 Cr |
| Total Liabilities | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr | ₹445 Cr |
| ASSETS | |||||
| Gross Block | ₹534 Cr | ₹371 Cr | ₹306 Cr | ₹223 Cr | ₹123 Cr |
| Less: Accumulated Depreciation | ₹81 Cr | ₹61 Cr | ₹45 Cr | ₹33 Cr | ₹23 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹453 Cr | ₹310 Cr | ₹262 Cr | ₹190 Cr | ₹100 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹148 Cr | ₹149 Cr | ₹68 Cr | ₹43 Cr | ₹79 Cr |
| Non Current Investments | ₹63 Cr | ₹64 Cr | ₹25 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Long Term Investment | ₹63 Cr | ₹64 Cr | ₹25 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹63 Cr | ₹64 Cr | ₹25 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Long Term Loans & Advances | ₹11 Cr | ₹0.68 Cr | ₹0.93 Cr | ₹3.98 Cr | ₹1.13 Cr |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹675 Cr | ₹523 Cr | ₹355 Cr | ₹237 Cr | ₹180 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹118 Cr | ₹85 Cr | ₹116 Cr | ₹92 Cr | ₹72 Cr |
| Raw Materials | ₹70 Cr | ₹58 Cr | ₹57 Cr | ₹40 Cr | ₹24 Cr |
| Work-in Progress | ₹28 Cr | ₹3.91 Cr | ₹30 Cr | ₹31 Cr | ₹24 Cr |
| Finished Goods | ₹19 Cr | ₹22 Cr | ₹26 Cr | ₹18 Cr | ₹22 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹1.33 Cr | ₹1.39 Cr | ₹2.87 Cr | ₹2.79 Cr | ₹1.76 Cr |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹134 Cr | ₹112 Cr | ₹85 Cr | ₹115 Cr | ₹74 Cr |
| Debtors more than Six months | ₹5.27 Cr | ₹0.90 Cr | ₹0.40 Cr | ₹1.03 Cr | ₹2.41 Cr |
| Debtors Others | ₹130 Cr | ₹112 Cr | ₹85 Cr | ₹116 Cr | ₹72 Cr |
| Cash and Bank | ₹79 Cr | ₹75 Cr | ₹158 Cr | ₹228 Cr | ₹89 Cr |
| Cash in hand | ₹0.02 Cr | ₹0.06 Cr | ₹0.23 Cr | ₹0.11 Cr | ₹0.17 Cr |
| Balances at Bank | ₹79 Cr | ₹75 Cr | ₹157 Cr | ₹228 Cr | ₹89 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹11 Cr | ₹16 Cr | ₹17 Cr | ₹13 Cr | ₹4.01 Cr |
| Interest accrued on Investments | ₹0.71 Cr | ₹4.51 Cr | ₹6.41 Cr | ₹6.03 Cr | ₹3.02 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹7.25 Cr | ₹1.00 Cr |
| Other current_assets | ₹0.21 Cr | ₹0.21 Cr | - | - | - |
| Short Term Loans and Advances | ₹99 Cr | ₹113 Cr | ₹90 Cr | ₹49 Cr | ₹26 Cr |
| Advances recoverable in cash or in kind | ₹66 Cr | ₹90 Cr | ₹67 Cr | ₹31 Cr | ₹8.54 Cr |
| Advance income tax and TDS | ₹5.03 Cr | ₹2.47 Cr | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹28 Cr | ₹20 Cr | ₹23 Cr | ₹18 Cr | ₹18 Cr |
| Total Current Assets | ₹442 Cr | ₹400 Cr | ₹465 Cr | ₹498 Cr | ₹265 Cr |
| Net Current Assets (Including Current Investments) | ₹355 Cr | ₹321 Cr | ₹369 Cr | ₹398 Cr | ₹119 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr | ₹445 Cr |
| Contingent Liabilities | ₹4.17 Cr | ₹3.46 Cr | ₹5.62 Cr | ₹5.62 Cr | ₹1.57 Cr |
| Total Debt | - | - | ₹17 Cr | ₹21 Cr | ₹70 Cr |
| Book Value | 123.84 | 101.31 | 86.91 | 76.50 | 36.70 |
| Adjusted Book Value | 123.84 | 101.31 | 86.91 | 76.50 | 36.70 |
Compare Balance Sheet of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,982.0 Cr | 3.1% | -0.6% | 35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 3.1% |
-0.6% |
35.8% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses